Guobang Pharma Ltd - Asset Resilience Ratio

Latest as of March 2026: 11.00%

Guobang Pharma Ltd (605507) has an Asset Resilience Ratio of 11.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 605507 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥1.25 Billion

≈ $183.44 Million USD Cash + Short-term Investments

Total Assets

CN¥11.40 Billion

≈ $1.67 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Guobang Pharma Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Guobang Pharma Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Guobang Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guobang Pharma Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.25 Billion	11.0%
Total Liquid Assets	CN¥1.25 Billion	11.00%

Asset Resilience Insights

Moderate Liquidity: Guobang Pharma Ltd has 11.00% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Guobang Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Guobang Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Guobang Pharma Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Guobang Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.32%	CN¥1.24 Billion ≈ $181.88 Million	CN¥10.98 Billion ≈ $1.61 Billion	+5.59pp
2024-12-31	5.73%	CN¥617.66 Million ≈ $90.38 Million	CN¥10.78 Billion ≈ $1.58 Billion	+1.23pp
2023-12-31	4.50%	CN¥465.99 Million ≈ $68.19 Million	CN¥10.36 Billion ≈ $1.52 Billion	-4.62pp
2022-12-31	9.12%	CN¥824.56 Million ≈ $120.66 Million	CN¥9.04 Billion ≈ $1.32 Billion	-7.63pp
2021-12-31	16.75%	CN¥1.26 Billion ≈ $184.12 Million	CN¥7.51 Billion ≈ $1.10 Billion	+16.75pp
2020-12-31	0.00%	CN¥34.78K ≈ $5.09K	CN¥5.51 Billion ≈ $806.08 Million	-3.15pp
2019-12-31	3.15%	CN¥149.87 Million ≈ $21.93 Million	CN¥4.76 Billion ≈ $696.45 Million	--

pp = percentage points

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.24 Billion

CN¥8.51 Billion CNY

Market Cap Rank

#8128 Global

#1957 in China

Share Price

CN¥15.22

Change (1 day)

-0.59%

52-Week Range

CN¥14.96 - CN¥29.25

All Time High

CN¥43.71